Macrophage-mediated cancer drug delivery
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Materials Today Sustainability
- Vol. 11-12
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (FT140100726)
- Australian Research Council (DP200101238)
This publication has 71 references indexed in Scilit:
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the LiteraturePLOS ONE, 2012
- Monocytes and Macrophages in Cancer: Development and FunctionsCancer Microenvironment, 2012
- The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal CancerPLOS ONE, 2012
- Origins of tumor-associated macrophages and neutrophilsProceedings of the National Academy of Sciences, 2012
- Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer modelInternational Journal of Nanomedicine, 2012
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentNature, 2011
- Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor developmentOncogene, 2011
- Molecular mechanisms regulating macrophage response to hypoxiaFrontiers in Immunology, 2011
- Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissuesBlood, 2004
- Macrophage colony‐stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppressionEuropean Journal of Immunology, 1993